Cargando…

Response to Wu et al. — Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong

A recently published paper that assessed the comparative cost-effectiveness of the 2 pneumococcal conjugate vaccines (PCVs) in Malaysia and Hong Kong reported that the 13-valent PCV vaccine (PCV13) is a better choice compared to the 10-valent pneumococcal non-typeable Haemophilus influenzae protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varghese, Lijoy, Mungall, Bruce, Zhang, Xu-Hao, Hoet, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084998/ https://www.ncbi.nlm.nih.gov/pubmed/27459265 http://dx.doi.org/10.1080/21645515.2016.1192738

Ejemplares similares

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand
por: Varghese, Lijoy, et al.
Publicado: (2018)

Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018
por: McGirr, Ashleigh, et al.
Publicado: (2018)

Reply to Wu et al.
por: Brittain, Evan L., et al.
Publicado: (2023)

Persistence of Pneumococcal Serotype 3 in Adult Pneumococcal Disease in Hong Kong
por: Subramanian, Reema, et al.
Publicado: (2021)

Response to Shami et al. ‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’ (Hum Vacc Immunother 2020)
por: Buchwald, Ulrike K., et al.
Publicado: (2020)

Clinical Therapeutics in Hong Kong
por: Cheung, Bernard M.Y., et al.
Publicado: (2019)

LINC-20. INFANT BRAIN TUMOURS IN HONG KONG
por: Shing, Matthew M K, et al.
Publicado: (2020)

Comparison of influenza disease burden in older populations of Hong Kong and Brisbane: the impact of influenza and pneumococcal vaccination
por: Yang, Lin, et al.
Publicado: (2019)

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong
por: Mohanty, Salini, et al.
Publicado: (2022)

An International Comparison of Women's Health Issues in the Philippines, Thailand, Malaysia, Canada, Hong Kong, and Singapore: The CIDA-SEAGEP Study
por: Choi, Bernard
Publicado: (2004)

Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong
por: Teng, Jade L L, et al.
Publicado: (2021)

Plants of Hong Kong /
por: Thrower, S. L.
Publicado: (1971)

Hospital in Hong Kong
Publicado: (1892)

Melioidosis in Hong Kong
por: Lui, Grace, et al.
Publicado: (2018)

Hong Kong Medical Journal – the Premier General Medical Journal in Hong Kong
por: Li, Kenneth KW, et al.
Publicado: (2021)

Cost of Cerebellar Ataxia in Hong Kong: A Retrospective Cost-of-Illness Analysis
por: Stanley, Winser John, et al.
Publicado: (2020)

Evidence for Elizabethkingia anophelis Transmission from Mother to Infant, Hong Kong
por: Lau, Susanna K.P., et al.
Publicado: (2015)

Hong Kong, 1997 : the final settlement /
por: Bonavia, David, 1940-
Publicado: (1985)

Political dictionary for Hong Kong
por: Davies, Stephen
Publicado: (1990)

Chikungunya Fever, Hong Kong
por: Lee, Nelson, et al.
Publicado: (2006)

Urban farming in Hong Kong
por: Chan, Daniel Wai-tin
Publicado: (2015)

Sanitary State of Hong-Kong
por: Black, W. T.
Publicado: (1869)

The Hong Kong Academy of Medicine
por: Halnan, Keith E.
Publicado: (1992)

Carbapenem resistance in Hong Kong
por: Harris, Margaret
Publicado: (2005)

Hong Kong’s gloom and doom
por: Morton, Brian
Publicado: (2003)

Thoracic surgery in Hong Kong
por: Chang, Aliss T. C., et al.
Publicado: (2022)

Cross-Sectional Study on Attitudes among General Practitioners towards Pneumococcal Vaccination for Middle-Aged and Elderly Population in Hong Kong
por: Mui, Lancelot W. H., et al.
Publicado: (2013)

Further available immunization option to prevent pneumococcal disease
por: Vojtek, Ivo, et al.
Publicado: (2015)

A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)
por: Moreira, Marta, et al.
Publicado: (2016)

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong
por: Cheung, Tak Hong, et al.
Publicado: (2021)

Comparative Cost-Effectiveness Analysis of Respiratory Syncytial Virus Vaccines for Older Adults in Hong Kong
por: Wang, Yingcheng, et al.
Publicado: (2023)

Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey
por: Voo, Teck Chuan, et al.
Publicado: (2022)

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
por: You, Joyce HS, et al.
Publicado: (2014)

Long-term care cost drivers and expenditure projection to 2036 in Hong Kong
por: Chung, Roger Y, et al.
Publicado: (2009)

Occupational Stress and Its Economic Cost in Hong Kong: The Role of Positive Emotions
por: Siu, Oi Ling, et al.
Publicado: (2020)

The economic strategy for the Hong Kong SAR: Evidence from productivity and cost analysis
por: Li, Kui-Wai
Publicado: (2005)

Response to article by Johnna Perdrizet et al.,“Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants”
por: Gómez, Jorge A., et al.
Publicado: (2021)

La casa de Hong-Kong /
por: Robbe-Grillet, Alain, 1922-2008
Publicado: (1968)

Del Guatao a Hong Kong
por: Ortega, Gregorio, 1926-
Publicado: (1986)

SARS-related Perceptions in Hong Kong
por: Lau, Joseph T.F., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_19efvq96vkbvl3hemurgu6q69c